Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cameron

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
Annals of Surgery|May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementVicente Valero, Tyler J Saunders, Jin He, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 9, 2020
Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinomaNing Pu, Shanshan Gao, Ross Beckman, et al.
Annals of Surgery|September 4, 2024
Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal AdenocarcinomaNorman G Nicolson, Joseph A Tandurella, Lawrence W Wu, et al.
Surgery|October 3, 2022
A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter studyAmmar A Javed, Alessandra Pulvirenti, Jian Zheng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 11, 2020
Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinomaNeda Amini, Neda Rezaee, Joseph R Habib, et al.
Endocrine Pathology|June 27, 2025
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-UpAshley L Kiemen, Eric D Young, Amanda L Blackford, et al.
Annals of Surgery|November 20, 2020
The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up AnalysisMichael J Pflüger, James F Griffin, Wenzel M Hackeng, et al.
Annals of Surgery|January 11, 2011
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activationEric Lutz, Charles J Yeo, Keith D Lillemoe, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-UpAshley L Kiemen, Eric D Young, Amanda L Blackford, et al.
Pancreas|June 18, 2024
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal AdenocarcinomaBenedict Kinny-Köster, Yembur Ahmad, Michael J Pflüger, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
Annals of Surgery|May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementVicente Valero, Tyler J Saunders, Jin He, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 9, 2020
Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinomaNing Pu, Shanshan Gao, Ross Beckman, et al.
Annals of Surgery|September 4, 2024
Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal AdenocarcinomaNorman G Nicolson, Joseph A Tandurella, Lawrence W Wu, et al.
Surgery|October 3, 2022
A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter studyAmmar A Javed, Alessandra Pulvirenti, Jian Zheng, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 11, 2020
Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinomaNeda Amini, Neda Rezaee, Joseph R Habib, et al.
Endocrine Pathology|June 27, 2025
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-UpAshley L Kiemen, Eric D Young, Amanda L Blackford, et al.
Annals of Surgery|November 20, 2020
The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up AnalysisMichael J Pflüger, James F Griffin, Wenzel M Hackeng, et al.
Annals of Surgery|January 11, 2011
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activationEric Lutz, Charles J Yeo, Keith D Lillemoe, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-UpAshley L Kiemen, Eric D Young, Amanda L Blackford, et al.
Pancreas|June 18, 2024
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal AdenocarcinomaBenedict Kinny-Köster, Yembur Ahmad, Michael J Pflüger, et al.
Pageof 29